Lv41
510 积分 2024-01-22 加入
Antibody-drug conjugates in gynaecological cancers: opportunities and challenges
5小时前
已完结
Avelumab in patients with gestational trophoblastic tumors with resistance to polychemotherapy: Cohort B of the TROPHIMMUN phase 2 trial
13天前
已完结
Trastuzumab rezetecan, a HER2-directed antibody-drug conjugate, in patients with advanced HER2-mutant non-small-cell lung cancer (HORIZON-Lung): phase 2 results from a multicentre, single-arm study
1个月前
已完结
Innovative, early-phase clinical trials of drug–radiotherapy combinations
1个月前
已完结
Bulumtatug Fuvedotin (BFv, 9MW2821), a next-generation Nectin-4 targeting antibody–drug conjugate, in patients with advanced solid tumors: a first-in-human, open-label, multicenter, phase I/II study
1个月前
已完结
Exploiting the folate receptor α in oncology
2个月前
已完结
Second-line olaparib maintenance therapy is associated with poor response to subsequent chemotherapy in BRCA1/2-mutated epithelial ovarian cancer: A multicentre retrospective study
2个月前
已完结
妇科恶性肿瘤抗HER-2治疗的研究进展
3个月前
已完结
Camrelizumab plus apatinib in patients with high-risk chemorefractory or relapsed gestational trophoblastic neoplasia (CAP 01): a single-arm, open-label, phase 2 trial
6个月前
已完结
皖公网安备34019202002308
